Achieve Life Sciences ACHV Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $10.46M-29.0% | $14.73M+0.3% | $14.69M+16.9% | $12.56M-2.6% | $12.89M+5.8% | ||
| $274K+9.2% | $251K+30.7% | $192K+0.5% | $191K+3.2% | $185K-6.1% | ||
| $295K+328% | $69K-72.5% | $251K+262% | -$155K-331% | $67K+139% | ||
| —— | 0%— | —— | —— | —— | ||
| -$10.17M+30.7% | -$14.66M-1.5% | -$14.44M-13.5% | -$12.72M+0.8% | -$12.83M-3.8% | ||
| -$0.19+26.9% | -$0.26+7.1% | -$0.28+24.3% | -$0.370.0% | -$0.37-2.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Achieve Life Sciences profitable?
- Achieve Life Sciences is not currently profitable: it reported a net loss of $52.0M over the trailing twelve months.
- What is Achieve Life Sciences's earnings per share?
- Achieve Life Sciences's diluted EPS over the trailing twelve months is $-1.10.
- Where does Achieve Life Sciences's income statement data come from?
- Every line is extracted from Achieve Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.